Publication | Closed Access

Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial

Breast OncologyPhase IiMedicinePharmacologyClinical TrialsBreast CancerPharmacotherapyHormone-receptor-negative Breast CarcinomaCancer TreatmentOncologyRadiation OncologyHealth Sciences